Literature DB >> 23105209

Current perspectives on laboratory markers for the assessment of cardiovascular disease and myocardial damage.

S Narayanan1.   

Abstract

The disruption of the endothelim is a prelude to the evolution of arteriosclerosis. Nitric oxide is critical to endothelial function. The oxidation of low density lipoprotein (LDL) mediated by small dense LDL particles contributes to the development of cardiovascular disease. The multiple effects of homocysteine including its potentiating the binding of lipoprotein(a) (LP(a)) to fibrin and its role in the formation of small dense LDL particles highlights its importance in the evolution of cardiovascular disease and justifies its measurement. Problems in measurement of homocysteine should be kept in perspective. The measurement of release of proteins from the cardiac contractile apparatus such as Troponin I has advantages over conventional measurement of cardiac enzymes and isozymes.

Entities:  

Keywords:  Cardiovascular disease; Homocysteine, LP(a); Troponin-I; myocardial damage; nitric oxide; small dense LDL

Year:  1999        PMID: 23105209      PMCID: PMC3453586          DOI: 10.1007/BF02867909

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  48 in total

Review 1.  Current concepts of coagulation and fibrinolysis.

Authors:  S Narayanan; N Hamasaki
Journal:  Adv Clin Chem       Date:  1998       Impact factor: 5.394

Review 2.  Endothelins.

Authors:  E R Levin
Journal:  N Engl J Med       Date:  1995-08-10       Impact factor: 91.245

3.  Potential role of human cytomegalovirus and p53 interaction in coronary restenosis.

Authors:  E Speir; R Modali; E S Huang; M B Leon; F Shawl; T Finkel; S E Epstein
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

4.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.

Authors:  T J Anderson; I T Meredith; A C Yeung; B Frei; A P Selwyn; P Ganz
Journal:  N Engl J Med       Date:  1995-02-23       Impact factor: 91.245

Review 5.  Myocardial markers of injury. Evolution and insights.

Authors:  J H Keffer
Journal:  Am J Clin Pathol       Date:  1996-03       Impact factor: 2.493

6.  Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.

Authors:  E J Schaefer; S Lamon-Fava; J L Jenner; J R McNamara; J M Ordovas; C E Davis; J M Abolafia; K Lippel; R I Levy
Journal:  JAMA       Date:  1994-04-06       Impact factor: 56.272

7.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

Authors:  G Liuzzo; L M Biasucci; J R Gallimore; R L Grillo; A G Rebuzzi; M B Pepys; A Maseri
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

Review 8.  Molecular therapies for vascular diseases.

Authors:  G H Gibbons; V J Dzau
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

Review 9.  Molecular genetic insights into cardiovascular disease.

Authors:  M T Keating; M C Sanguinetti
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

10.  Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells.

Authors:  M Ohba; M Shibanuma; T Kuroki; K Nose
Journal:  J Cell Biol       Date:  1994-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.